Research > ETFs > ETF / ETP Commentary > 

NVDA, the CapEx Cycle & the 2027 AI Outlook

2026 has been a roller coaster ride for the story of AI stocks. From the model wars to the hyperscalers and data center drama, investors have had a lot to think about. The recent VettaFi 2027 Market Outlook Symposium explored the 2027 AI outlook as well as how investors should square the Nvidia (NVDA), the CapEx cycle, and advancements in AI and robotics.Key Takeaways: The 2027 AI outlook may be colored by the drama this year, but the CapEx cycle still appeals. VettaFi’s latest webcast emphasized how robotics and AI advances interact and boost the overall case. Funds like ROBO and CHIP offer exposure to those key themes ahead of 2027. The symposium segment “The Evolving AI Opportunity,” hosted by VettaFi Director of Research Cinthia Murphy, included insight from REX Financial Managing Director Bill Birmingham and VettaFi Head of Robotics & AI Research Zeno Mercer. The duo answered Murphy’s questions on topics ranging from the AI CapEx cycle to the changing chip production landscape. In discussing the latest news surrounding NVDA and ex-CEO Jenson Huang, Mercer underscored the importance of the new phase of AI. The AI trade is more than just data centers, he said. “I think part of this is understanding what are all the phases of AI?” Mercer said. “AI is not just data centers. It’s becoming more distributed. … So, we are starting to see different sectors of the AI economy. I like to call it the inference economy taking off.” That, he said, includes the blossoming of segments like the cloud and cybersecurity in Q3. That also includes further benefits down the line of the “J curve” from the upfront investment. The “flywheel” of distributed intelligence connecting the cloud to automation, robotics, and more is starting to come online, he explained.How Chip Advances Figure Into the AI OutlookOne of the big stories in the 2027 AI outlook, per Birmingham, relates to the changing picture of chip manufacturing. Birmingham and the folks at REX launched the REX Chipmaking ETF CHIP to offer exposure therein. In doing so, the firm wanted an ETF to target underrepresented chip segments relative to the design and fabrication layers. Now, Birmingham said, taking into account all those layers, leading-edge chips take around 1,400 steps to complete. As 3D chip design grows, he added, he sees plenty of high-quality chipmaking firms with healthy moats. CHIP breaks the chipmaking landscape into three tranches, he said: wafers, like those by ASML, advanced packaging, and metrology, and test. “The biggest problem that they have in this sector is that they’re supply-constrained,” he said. “I think it was ASML that might’ve mentioned that they’re going to add 30% capacity next year and it was completely sold out. It was not enough to even meet demand for ‘27 and ‘28. So there is some real cap and some real opportunity here.” In robotics, Mercer pointed to accelerated adoption as AI empowers robotics, and robots help construct data centers. He and his team of researchers see robotics as a win now and later based on adoption and innovation trends. “It’s winning now as it’s helping make these, and it’s going to see adjustable market expansion from AI with better skills and more skills. It can do more tasks,” Mercer said. We’re seeing automation happening in the warehouse, but we’re seeing those fine-tuned skills being more generalist,” he added. “Basically, all the components you hear about come together beautifully in the robotic space because it enhances what can be done off the edge with more random environments, less structured environments.”2027 AI Outlook & RoboticsMercer and his colleagues are watching the development of so-called dextrous hands in robotics as an important next phase. They claim they’ve identified more than $1 trillion that unlock if that one modality of robotics can be solved. Speaking to that “win now and later” case, he said some 92% of the ROBO Global Robotics and Automation Index is currently profitable. See more: Webcast: What M&A Trends Say About AI, Robotics & More Funds like the ROBO Global Robotics & Automation ETF ROBO that follow that index and CHIP help capture that holistic growth in the 2027 AI outlook. That suite of ETFs offers exposure to the combined and sometimes-overlapping benefits in those key tech and AI-related segments. “I think what we haven’t seen yet that is going to come in the AI economy is an app layer that really abstracts and orchestrates the model choice underneath the hood,” Birmingham said. “I think if you really want to have exposure to the broadening ROI story for this inference economy, you do need to start diversifying your portfolio into the picks and shovels, into some of the more physical AI sectors, whether it’s robotics or other types of mobility,” he added. Looking for regular updates? Subscribe here for weekly insights on robotics, AI, and healthcare technology, delivered straight to your inbox. For more news, information, and analysis, visit the Thematic Investing Content Hub. vettafi.com is owned by VettaFi LLC (“VettaFi”). VettaFi is the index provider for ROBO and CHIP, for which it receives an index licensing fee. However, ROBO and CHIP are not issued, sponsored, endorsed, or sold by VettaFi. VettaFi and its affiliates have no obligation or liability in connection with the issuance, administration, marketing, or trading of ROBO or CHIP.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.